logo
Alkem Laboratories Ltd.
18 Feb 2026, 12:00AM
5200.50
0.49%
Motilal Oswal
Alkem Lab (ALKEM) is advancing its MedTech strategy through the acquisition of up to a 55% stake in Occlutech for ~EUR99m (~INR10.6b), gaining control of a specialist in minimally invasive devices for congenital heart disease, stroke prevention, and heart failure.
BOB Capital Markets Ltd. decreased Sell price target of Alkem Laboratories Ltd. to 4589.0 on 13 Nov, 2026.
More from Alkem Laboratories Ltd.
Recommended